Chronic Pelvic Pain Treatment Market (Treatment: Medications, Surgery, and Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Chronic Pelvic Pain Treatment market size was estimated at USD 5.7 billion in 2021 and is expected to surpass around USD 8.9 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 3.10% during the forecast period 2022 to 2030.

Overview of Chronic Pelvic Pain Treatment Market

Pelvic pain occurs in the pelvic region (the pelvic bone or reproductive organs) in females or males. It is termed chronic when it lasts for six months or more. According to the European Association of Urology (EAU), chronic or persistent pain in structures related to the pelvis of either men or women is termed pelvic pain. Chronic pelvic pain is often associated with behavioral, negative cognitive, and emotional consequences as well as with symptoms indicative of lower urinary tract, pelvic floor, or gynecological dysfunction. Various endoscopic devices are being introduced in the market for accurate diagnosis of chronic pelvic pain. Effective management of chronic pelvic pain care and treatment in healthcare centers is expected to create significant opportunities for market players.

Report Scope of the Chronic Pelvic Pain Treatment Market

Rise in Awareness about Treatment for Chronic Pelvic Pain to Drive Global Market

Chronic pelvic pain frequently coexists with non-pelvic pain disorders (e.g. fibromyalgia and migraines) and non-pain comorbidities (e.g. sleep, mood, and cognitive impairment) leading to severe pain and disability. For instance, 50% to 90% of patients with chronic pelvic pain experience musculoskeletal pain and dysfunction. Changes in lifestyle, consumption of hybrid food, increase in pollution, stress, anxiety, and depression could lead to diseases that cause pelvic pain, especially in women. Delay in receiving chronic pelvic pain treatment causes unnecessary suffering from a condition that could be improved with proper management. Rise in awareness about chronic pelvic pain causes and treatment is likely to create growth opportunities for market players.

Easy Access, Cost-effectiveness, and Quick-relief Medications Augmenting Global Market

In terms of treatment, the global chronic pelvic pain treatment market has been classified into medications, surgery, and others. The medications segment has been split into pain relievers, hormone treatments, antibiotics, and antidepressants. The medications segment dominated the global chronic pelvic pain treatment market with around 70% in 2021. The trend is projected to continue during the forecast period. Rise in awareness about the availability of medications for pain management is driving consumption and acceptance of pain management drugs over other treatment options. Medications are the first and primary treatment options provided to patients suffering from chronic pelvic pain. OTC pain relievers are one of the most commonly used drugs in the world. NSAIDs and some other non-opioids such as paracetamol, codeine, ibuprofen, and Aspirin (acetylsalicylic acid) are the most consumed drugs across the globe. According to the FDA, nearly eight in 10 prescriptions filled in the U.S. are for generic drugs. Hence, rise in usage of generic drugs for chronic pelvic pain is expected to drive the market for chronic pelvic pain treatment in the next few years.

Growth in Preference for OTC Painkillers and Other Medications to Boost Retail Pharmacies & Drug Stores Segment

Based on distribution channel, the global chronic pelvic pain treatment market has been divided into retail pharmacies & drug stores, e-commerce, and others. The retail pharmacies & drug stores segment held major share of around 65% in 2021. Growth of the segment can be ascribed to the increase in preference for over-the-counter painkillers and other medications in pharmacies and drug stores.

Regional Outlook of Global Chronic Pelvic Pain Treatment Market

North America accounted for the largest share of around 36.4% of the global market in 2021, owing to the increase in incidence of chronic pelvic pain in the region. According to the NCBI, one in seven women in the U.S. suffers from chronic pelvic pain. Europe held around 31.2% share of the global market in 2021. The market in the region is growing at a rapid pace due to the rise in awareness about treatments and increase in number of complete body check-ups. This can help people identify the cause of chronic pelvic pain and avail the correct treatment. Asia Pacific accounted for a larger share of the market than Latin America and Middle East & Africa in 2021. However, the market in Latin America is anticipated to grow at a faster CAGR than that in Middle East & Africa during the forecast period.

Analysis of Key Players in Chronic Pelvic Pain Treatment Market

The chronic pelvic pain treatment market report concludes with the company profiles section, which includes key information about the leading players in the global chronic pelvic pain treatment market. Leading players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, GlaxoSmithKline plc, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, and Perrigo Company plc.

Key Developments in Global Chronic Pelvic Pain Treatment Market

• According to the National Institutes of Health (NIH), duloxetine, an FDA-approved drug for other pain treatments, is under clinical trial to check its effectiveness in treating chronic pelvic pain in women
• In February 2020, Baxter International, Inc. announced that it had completed the acquisition of the Seprafilm adhesion barrier and other related assets from Sanofi. Seprafilm is an adhesion barrier that reduces the severity of adhesions following abdominopelvic surgery.

Some of the prominent players in the Chronic Pelvic Pain Treatment Market include:

• Bayer AG
• Becton, Dickinson and Company
• GlaxoSmithKline plc.
• Hospiinz
• Intuitive Surgical
• MAST PAK SURGICAL CORP
• Mayne Pharma Group Limited
• Medtronic
• Perrigo Company plc

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Chronic Pelvic Pain Treatment market

• Technology
• Medications
• Pain Relievers
• Hormone Treatments
• Antibiotics
• Antidepressants
• Surgery
• Laparoscopic Surgery
• Hysterectomy
• Others
• Distribution Channel
• Retail Pharmacies & Drug stores
• E-commerce
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Chronic Pelvic Pain Treatment industry analysis from 2022 to 2030 to identify the prevailing Chronic Pelvic Pain Treatment industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Chronic Pelvic Pain Treatment industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Chronic Pelvic Pain Treatment industry trends, key players, market segments, application areas, and market growth strategies.